FDA recall record

Reckitt Benckiser Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg recall — FDA D-310-2013

Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Class IIIclassification
D-310-2013official record ID
May 8, 2013report date

Recall record at a glance

Official recordD-310-2013
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmReckitt Benckiser Inc.
Report dateMay 8, 2013
Recall initiation dateMar 18, 2013
Quantity27,718 cases 16 count and 7,551 cases 576 count
LocationParsippany, NJ, United States

Official product description

Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054

Why the product was recalled

Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.